HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-bromosaccharin

structure given in first source

Also Known As:

NBSA

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Saccharin: 632
      - N-bromosaccharin: 9
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Benzothiazoles: 40
        Saccharin: 632
        N-bromosaccharin: 9
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzothiazoles: 40
      - Saccharin: 632
        N-bromosaccharin: 9

Experts

1.	Liu, Gan: 2 articles (05/2018 - 01/2017)
2.	Mei, Lin: 2 articles (05/2018 - 01/2017)
3.	Tsai, Hsiang-I: 2 articles (05/2018 - 01/2017)
4.	Zeng, Xiaowei: 2 articles (05/2018 - 01/2017)
5.	Hu, Wenhao: 1 article (12/2020)
6.	Huang, Shiyong: 1 article (12/2020)
7.	Zhang, Jian: 1 article (12/2020)
8.	Zhao, Tian: 1 article (12/2020)
9.	Zheng, Lili: 1 article (12/2020)
10.	Chen, Hongbo: 1 article (05/2018)

Related Diseases

1.	Hemoptysis 12/01/2020 - "Therefore, the purpose of the present study was to retrospectively assess the risk factors of recurrent hemoptysis patients with NBSA feeding after interventional embolization. " 07/01/2022 - "Among the 300 patients treated for hemoptysis with bronchial artery and NBSA embolization between April 2018 and July 2019, 19 procedures in 19 patients were conducted by TRA and were retrospectively analyzed. " 07/01/2022 - "PURPOSE We aimed to determine the safety and feasibility of transradial access (TRA) in bronchial artery and non-bronchial systemic artery (NBSA) embolization in patients with non-massive hemoptysis. "
2.	Liver Neoplasms (Liver Cancer) 01/01/2017 - "The in vitro results show that the Dox-conjugated nanocapsule (nBSA-Dox) released the drug under an acidic tumor microenvironment (pH ~6.5) and killed HepG2 human liver cancer cells. " 05/14/2018 - "In vitro results showed this nanocapsule could be efficiently uptaken by the Dox-resistant HepG2/ADR human liver cancer cells through clathrin-mediated endocytosis and greatly prevented the Dox efflux, causing much more cytotoxicity than free Dox and non-TPGS-decorated nBSA-Dox. "
3.	Neoplasms (Cancer) 05/14/2018 - "Furthermore, nBSA-TPGS-Dox exhibited much prolonged in vivo half-life compared to conventional PEGylated nanoparticles and achieved excellent tumor accumulation. " 05/14/2018 - "Finally, this TPGS-decorated stealthy nanocapsule performed outstanding suppression of Dox-resistant tumor, much superior than non TPGS-decorated nBSA-Dox and free Dox. "
4.	Pulmonary Hypertension 08/14/2023 - "BAE and/or NBSAE can effectively reduce pulmonary hypertension in patients with a BA-PA and/or NBSA-PA fistula."
5.	Glioma (Gliomas) 05/02/2017 - "Furthermore, temozolomide (TMZ), which can be loaded onto the nanoparticles via electrostatic interactions with acrylic acid (AA) to generate AA-nBSA-SA-TMZ, was applied as an excellent chemotherapeutic drug for glioma therapy. "

Related Drugs and Biologics

1.	Nanocapsules
2.	Bovine Serum Albumin
3.	Proteins (Proteins, Gene)
4.	Hexadimethrine Bromide
5.	Doxorubicin (Adriamycin)
6.	Clathrin
7.	Albumins
8.	Temozolomide (Temodar)
9.	acrylic acid (acrylate)
10.	tocophersolan

Related Therapies and Procedures

1.	Therapeutics